2.87 USD
+0.36 (+14.34%)
2.82 USD
-0.05 (-1.74%)
We assign a fundamental rating of 3 out of 10 to NHTC. NHTC was compared to 35 industry peers in the Personal Care Products industry. NHTC has a great financial health rating, but its profitability evaluates not so good. NHTC does not seem to be growing, but still is valued expensively. NHTC also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
NHTC had negative earnings in the past year.
NHTC had a negative operating cash flow in the past year.
In the past 5 years NHTC has always been profitable.
In multiple years NHTC reported negative operating cash flow during the last 5 years.
1.2 Ratios
NHTC has a Return On Assets (0.77%) which is comparable to the rest of the industry.
NHTC has a Return On Equity of 1.21%. This is comparable to the rest of the industry: NHTC outperforms 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.77% | ||
| ROE | 1.21% | ||
| ROIC | N/A |
ROA(3y)0.74%
ROA(5y)0.82%
ROE(3y)1.23%
ROE(5y)1.35%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of NHTC (0.83%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of NHTC has declined.
NHTC has a Gross Margin of 73.97%. This is in the better half of the industry: NHTC outperforms 80.00% of its industry peers.
NHTC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 0.83% | ||
| GM | 73.97% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-10.12%
PM growth 5YN/A
GM growth 3Y-0.45%
GM growth 5Y-0.03%
2. Health
2.1 Basic Checks
NHTC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NHTC remains at a similar level compared to 1 year ago.
NHTC has more shares outstanding than it did 5 years ago.
There is no outstanding debt for NHTC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
Based on the Altman-Z score of 1.78, we must say that NHTC is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.78, NHTC is doing worse than 60.00% of the companies in the same industry.
NHTC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.78 |
ROIC/WACCN/A
WACC8.7%
2.3 Liquidity
A Current Ratio of 2.73 indicates that NHTC has no problem at all paying its short term obligations.
NHTC's Current ratio of 2.73 is fine compared to the rest of the industry. NHTC outperforms 71.43% of its industry peers.
A Quick Ratio of 2.55 indicates that NHTC has no problem at all paying its short term obligations.
The Quick ratio of NHTC (2.55) is better than 77.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.73 | ||
| Quick Ratio | 2.55 |
3. Growth
3.1 Past
NHTC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -114.29%.
The earnings per share for NHTC have been decreasing by -17.90% on average. This is quite bad
Looking at the last year, NHTC shows a decrease in Revenue. The Revenue has decreased by -2.19% in the last year.
Measured over the past years, NHTC shows a very negative growth in Revenue. The Revenue has been decreasing by -11.15% on average per year.
EPS 1Y (TTM)-114.29%
EPS 3Y-17.9%
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-2.19%
Revenue growth 3Y-10.54%
Revenue growth 5Y-11.15%
Sales Q2Q%-11.32%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for NHTC. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 31.87%, NHTC is a good candidate for dividend investing.
In the last 3 months the price of NHTC has falen by -34.17%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
NHTC's Dividend Yield is rather good when compared to the industry average which is at 7.49. NHTC pays more dividend than 100.00% of the companies in the same industry.
NHTC's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 31.87% |
5.2 History
The dividend of NHTC has a limited annual growth rate of 4.44%.
NHTC has been paying a dividend for at least 10 years, so it has a reliable track record.
NHTC has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)4.44%
Div Incr Years0
Div Non Decr Years10
5.3 Sustainability
NHTC pays out 2647.41% of its income as dividend. This is not a sustainable payout ratio.
DP2647.41%
EPS Next 2YN/A
EPS Next 3YN/A
2.87
+0.36 (+14.34%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners15.96%
Inst Owner Change-6.13%
Ins Owners15.6%
Ins Owner Change0%
Market Cap33.03M
Revenue(TTM)42.96M
Net Income(TTM)348.00K
Analysts0
Price TargetN/A
Short Float %0.32%
Short Ratio0.53
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 31.87% |
Yearly Dividend0.8
Dividend Growth(5Y)4.44%
DP2647.41%
Div Incr Years0
Div Non Decr Years10
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.78 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.14 | ||
| P/tB | 1.14 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.48
FCFYN/A
OCF(TTM)-0.48
OCFYN/A
SpS3.66
BVpS2.51
TBVpS2.51
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.77% | ||
| ROE | 1.21% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 0.83% | ||
| GM | 73.97% | ||
| FCFM | N/A |
ROA(3y)0.74%
ROA(5y)0.82%
ROE(3y)1.23%
ROE(5y)1.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-10.12%
PM growth 5YN/A
GM growth 3Y-0.45%
GM growth 5Y-0.03%
F-Score4
Asset Turnover0.93
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 38.84% | ||
| Cap/Sales | 0.11% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.73 | ||
| Quick Ratio | 2.55 | ||
| Altman-Z | 1.78 |
F-Score4
WACC8.7%
ROIC/WACCN/A
Cap/Depr(3y)47.19%
Cap/Depr(5y)53.89%
Cap/Sales(3y)0.17%
Cap/Sales(5y)0.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-114.29%
EPS 3Y-17.9%
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.19%
Revenue growth 3Y-10.54%
Revenue growth 5Y-11.15%
Sales Q2Q%-11.32%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-16.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.25%
OCF growth 3YN/A
OCF growth 5YN/A
NATURAL HEALTH TRENDS CORP / NHTC FAQ
What is the fundamental rating for NHTC stock?
ChartMill assigns a fundamental rating of 3 / 10 to NHTC.
Can you provide the valuation status for NATURAL HEALTH TRENDS CORP?
ChartMill assigns a valuation rating of 0 / 10 to NATURAL HEALTH TRENDS CORP (NHTC). This can be considered as Overvalued.
What is the profitability of NHTC stock?
NATURAL HEALTH TRENDS CORP (NHTC) has a profitability rating of 3 / 10.
How financially healthy is NATURAL HEALTH TRENDS CORP?
The financial health rating of NATURAL HEALTH TRENDS CORP (NHTC) is 7 / 10.